Giulia Caron

Prof. Giulia Caron

Molecular Biotechnology and Health Sciences Department, University of Torino, Quarello 15, 10135 Torino, Italy

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2018 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MSMatteo Rossi Sebastiano
Matteo Rossi Sebastiano
BDBradley C. Doak
Bradley C. Doak
MBMaria Backlund
Maria Backlund
VPVasanthanathan Poongavanam
Vasanthanathan Poongavanam
BOBjörn Over
Björn Over
JKJan Kihlberg
Jan Kihlberg

19 January 2019 in Medicinal Research Reviews
Verified
Journal Article
Closed access
PDF file
Giulia CaronGiulia Caron
Giulia Caron
JKJan Kihlberg
Jan Kihlberg
GEGiuseppe Ermondi
Giuseppe Ermondi

1 December 1997 in Chemical Reviews
Verified
Journal Article
Closed access
APAlessandra Pagliara
Alessandra Pagliara
PCPierre-Alain Carrupt
Pierre-Alain Carrupt
Giulia CaronGiulia Caron
Giulia Caron
PGPatrick Gaillard
Patrick Gaillard
BTBernard Testa
Bernard Testa

1 April 2020 in Drug Discovery Today
Verified
Journal Article
Closed access
Giulia CaronGiulia Caron
Giulia Caron
VDVito Digiesi
Vito Digiesi
SSSara Solaro
Sara Solaro
GEGiuseppe Ermondi
Giuseppe Ermondi

6 February 2004 in Medicinal Research Reviews
Verified
Journal Article
Closed access
PDF file
GBGeorgette Plemper van Balen
Georgette Plemper van Balen
CMCatherine a Marca Martinet
Catherine a Marca Martinet
Giulia CaronGiulia Caron
Giulia Caron
GBGéraldine Bouchard
Géraldine Bouchard
MRMarianne Reist
Marianne Reist
BTBernard Testa
Bernard Testa

25 April 2022 in Journal of Medicinal Chemistry
Verified
Journal Article
Open access
DJDiego Jiménez
Diego Jiménez
MSMatteo Rossi Sebastiano
Matteo Rossi Sebastiano
MVMaura Vallaro
Maura Vallaro
VMValentina Mileo
Valentina Mileo
DPDaniela Pizzirani
Daniela Pizzirani
Giulia CaronGiulia Caron
Giulia Caron
Solubility optimization is a crucial step to obtaining oral PROTACs. Here we measured the thermodynamic solubilities (log S) of 21 commercial PROTACs. Next, we measured BRlogD and log kwIAM (lipophilicity), EPSA, and Δ log kwIAM (polarity) and showed that lipophilicity plays a major role in governing log S, but a contribution of polarity cannot be neglected. Two-/three-dimensional descriptors calculated on conformers arising from conformational sampling and steered molecular dynamics failed in modeling solubility. Infographic tools were used to identify a privileged region of soluble PROTACs in a chemical space defined by BRlogD, log kwIAM and topological polar surface area, while machine learning provided a log S classification model. Finally, for three pairs of PROTACs we measured the solubility, lipophilicity, and polarity of the building blocks and identified the limits of estimating PROTAC solubility from the synthetic components. Overall, this paper provides promising guidelines for optimizing PROTAC solubility in early drug discovery programs.